Emily Turton

BA (Dunelm) MA

Population Health, School of Medicine and Population Health

Data Specialist

e.j.turton@sheffield.ac.uk
+44 114 222 0685

Room 1.09b, The Innovation Centre

Full contact details

Emily Turton
Population Health, School of Medicine and Population Health
Room 1.09b
The Innovation Centre
217 Portobello
Sheffield
S1 4DP

Profile

I joined ScHARR in July 2012 as Clerical Officer for the NOSH (NOurishing Start for Health) project in the section of Public Health. I moved to DTS to take up a position as Data Management Assistant in the CTRU in July 2014.

Prior to this, I worked for the Admissions service at the University of Sheffield (2004 - 2008) and, most recently, for the Clinical Trials Unit at the University of Leeds (2010 - 2012), supporting the PURPOSE Pressure Ulcer Research Programme.

I graduated from the Universities of Durham and Leeds, with, respectively, a BA and MA in Classics. Outside work, I am an aspiring novelist seeking fame and fortune, or just publication credits.

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Burton C, Mooney C, Sutton L, White D, Dawson J, Neilson AR, Rowlands G, Thomas S, Horspool M, Fryer K , Greco M et al (2024) Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial. The Lancet, 403(10444), 2619-2629. View this article in WRRO
Petrie J, Loban A, Turton E, Derebecka J, North S, Herbert E & Hind D (2024) “Reality is frequently inaccurate” A case study examining the whens and whys of post-live database changes in a UK clinical trials unit *Douglas Adams. Contemporary Clinical Trials, 142. View this article in WRRO
Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA , Graham CD et al (2024) Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK. The Lancet. View this article in WRRO
Keetharuth AD, Gould R, McDermott C, Thompson B, Rawlinson C, Bradburn M, Bursnall M, Kumar P, Turton E, Tappenden P , White D et al (2024) Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life. European Journal of Neurology. View this article in WRRO
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Din S , Emsley R et al (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11(3). View this article in WRRO
Jones G, Bailey L, Beeken RJ, Brady S, Cooper C, Copeland RJ, Crosland S, Dawson S, Faires M, Gilbody S , Haynes H et al (2024) Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trial. Pilot and Feasibility Studies, 10(1). View this article in WRRO
Lindsay JO, Hind D, Swaby E, Berntsson H, Bradburn M, Bannur U, Byrne J, Clarke C, Desoysa L, Dickins B , Din S et al (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. View this article in WRRO
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technology Assessment, 26(39). View this article in WRRO
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet, 400(10353), 680-690. View this article in WRRO
Mountain G, Wright J, Cooper CL, Lee E, Sprange K, Beresford-Dent J, Young T, Walters S, Berry K, Dening T , Loban A et al (2022) An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia : the Journeying through Dementia RCT. Health Technology Assessment, 26(24), 1-151. View this article in WRRO
Mountain GA, Cooper CL, Wright J, Walters SJ, Lee E, Craig C, Berry K, Sprange K, Young T, Moniz-Cook E , Dening T et al (2022) The Journeying through Dementia psychosocial intervention versus usual care study: a single-blind, parallel group, phase 3 trial. The Lancet Healthy Longevity, 3(4), e276-e285. View this article in WRRO
Shanahan TAG, Fuller GW, Sheldon T, Turton E, Quilty FMA & Marincowitz C (2021) External validation of the Dutch prediction model for prehospital triage of trauma patients in South West region of England, United Kingdom. Injury, 52(5), 1108-1116. View this article in WRRO